- Online Program Overview
- Learning Objectives
- Credits and Logistics
- Who Should Participate
Online Program Overview
Promoting Evidence-Based Environmental, Health, and Safety Policies
Benefit-cost analysis is a well-established and widely used approach for systematically assessing the impacts of environmental, health, and safety policies and informing decisions. It is often a required component of the policy development process followed by many government agencies and organizations around the world.
During the COVID-19 epidemic, benefit-cost analysis has received unprecedented attention by playing an important role in highlighting key trade-offs and informing response efforts and related policies. However, this attention has highlighted confusion about the overall framework, its advantages and limitations, and the approaches used to value mortality risk reductions, commonly referred to as the value per statistical life (VSL). Understanding the appropriate use of benefit-cost analysis and its implications is crucial given the importance of promoting evidence-based decisions as we begin to emerge from the epidemic and face many other crucial policy challenges.
In this short online program, Lisa A. Robinson, a leading Harvard expert on benefit-cost analysis, will aid you in understanding the benefit-cost analysis framework and its application globally. You will learn the methods used for valuing changes in health and longevity, the values recommended for use in high-, middle-, and low-income settings, and the implications of the results. Through interactive presentations, case studies, extensive discussion, and optional office hours, you will develop a deeper understanding of these approaches and of their application.
You will leave this program understanding the advantages and limitations of benefit-cost analysis, improving your ability to evaluate, interpret, and use the results.
Understanding Policy Trade-Offs: Are the Benefits Worth the Costs?
Benefit-cost analysis estimates the positive and negative impacts of a policy, clarifying the trade-offs implicit in the policy decision. As illustrated by the COVID-19 pandemic, the core challenge involves assessing the extent to which saving lives should take precedence over incurring economic damages and other costs.
Benefit-cost analysis, which is also known as cost-benefit analysis or return on investment analysis, is used in many other contexts to evaluate environmental, health, and safety policies. For example, it has played a major role in developing air pollution policies, motor vehicle safety regulations, smoking restrictions, and food safety requirements. In each case, benefit-cost analysis addresses the central question: are the benefits provided worth the costs incurred?
- Understand the fundamental concepts that underlie benefit-cost analysis and its advantages and limitations
- Identify the major components of a benefit-cost analysis and what each should include
- Increase familiarity with methods for valuing health and longevity, including revealed- and stated-preference studies and their application
- Learn about sources of guidance, including default values
Major topics to be covered in the course will include:
- Benefit-Cost Analysis Framework
- Conceptual foundation
- Individual preferences and willingness to pay
- Aggregate social welfare and distributional equity
- Implementation components and steps
- Valuing Longevity
- Value per statistical life (VSL) concept
- Market and nonmarket valuation methods
- Human capital
- Revealed and stated preferences
- Benefits transfer
- Guidance and recommended values
- Valuing Health
- Value per statistical case (VSC) concept
- Available valuation studies
- Proxy methods
- Averted costs (direct and indirect cost of illness)
- Monetized quality-adjusted life years (QALYs) and disability-adjusted life years (DALYs)
Credits and Logistics
Continuing Education Credit
Harvard T.H. Chan School of Public Health will grant Continuing Education Units (CEUs) for this program. Specific credit counts will be published when available; please check back for updated information.
All credits subject to final agenda.
All participants will receive a Certificate of Participation upon completion of the program.
Current faculty, subject to change.
Center for Health Decision Science and Center for Risk Analysis
Center for Health Decision Science
Harvard T.H. Chan School of Public Health
September 27, 2021 – October 1, 2021back to top
This agenda is subject to change. All times listed are in Eastern Time (ET).
|Monday, September 27, 2021|
|11:00–11:00 am||Robinson||Session I: Concepts and Framework: Conceptual Foundations, Components, and Steps|
|11:00–11:15 am||Robinson||Welcome, Introductions and Overview|
|11:15–11:45 am||Robinson||Conceptual Foundation|
|11:45 am–12:30 pm||Robinson||Components and Steps|
|12:30–1:30 pm||Case Study 1||Tuesday, September 28, 2021|
|11:30 am–12:30 pm||Optional Office Hours||Wednesday, September 29, 2021|
|11:00–11:00 am||Robinson||Session II: Valuing Longevity: Value Per Statistical Life Concept & Application|
|11:00–11:30 am||Robinson||Value per Statistical Life (VSL) Concept|
|11:30 am–12:00 pm||Robinson||Market and Nonmarket Valuation Methods|
|12:00–12:30 pm||Robinson||Guidance and Recommended Values|
|12:30–1:30 pm||Case Study 2||Thursday, September 30, 2021|
|11:30 am–12:30 pm||Optional Office Hours||Friday, October 1, 2021|
|11:00–11:00 am||Robinson||Session III: Valuing Health: Value Per Statistical Case Concept and Application|
|11:00–11:15 am||Robinson||Value per Statistical Case (VSC) Concept|
|11:15–11:45 am||Robinson||Available Valuation Studies|
|11:45 am–12:15 pm||Robinson||Proxy Methods: Averted Costs, Monetized QALYs and DALYs|
Who Should Participate
This course is designed for practitioners, policymakers, and other stakeholders who want to increase their understanding of benefit-cost analysis and its application to environmental, health, and safety policies globally, and already have a basic understanding of approaches for economic evaluation and the benefit-cost analysis framework.
Examples of participants include:
- Economists who conduct benefit-cost analyses
- Managers who commission and review benefit-cost analyses
- Researchers who contribute inputs to these analyses, such as estimates of deaths averted or technology effectiveness
- Stakeholders who participate in the policymaking process, such as interest group representatives and congressional staff
This program addresses policies to be implemented in high-, middle-, and low-income countries that are likely to lead to health improvements, making it valuable for participants across the globe. Potential participants will come from a range of employer types, including government agencies, foundations, universities, non-profits, and other health-focused organizations.